Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
119.99
+2.99 (2.56%)
At close: Sep 26, 2025, 4:00 PM EDT
120.00
+0.01 (0.01%)
After-hours: Sep 26, 2025, 7:55 PM EDT
Teleflex Revenue
Teleflex had revenue of $780.89M in the quarter ending June 29, 2025, with 4.16% growth. This brings the company's revenue in the last twelve months to $3.04B, up 1.11% year-over-year. In the year 2024, Teleflex had annual revenue of $3.05B with 2.45% growth.
Revenue (ttm)
$3.04B
Revenue Growth
+1.11%
P/S Ratio
1.81
Revenue / Employee
$215,698
Employees
14,100
Market Cap
5.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.05B | 72.84M | 2.45% |
| Dec 31, 2023 | 2.97B | 183.45M | 6.57% |
| Dec 31, 2022 | 2.79B | -18.52M | -0.66% |
| Dec 31, 2021 | 2.81B | 272.41M | 10.74% |
| Dec 31, 2020 | 2.54B | -58.21M | -2.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
TFX News
- 16 days ago - First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients - GlobeNewsWire
- 17 days ago - Teleflex Incorporated (TFX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy - GlobeNewsWire
- 2 months ago - Teleflex Incorporated (TFX) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - Teleflex Announces Quarterly Dividend - GlobeNewsWire
- 2 months ago - Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook - GlobeNewsWire
- 2 months ago - Chest Drainage Catheters Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Leading Players - BD, Teleflex, Cook, ICU Medical, and Redax - GlobeNewsWire